| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.02B | 55.91B | 54.41B | 53.42B | 48.52B | 42.34B |
| Gross Profit | 25.43B | 26.14B | 26.08B | 24.48B | 21.34B | 18.23B |
| EBITDA | 8.31B | 8.05B | 8.39B | 8.43B | 7.91B | 6.54B |
| Net Income | 4.12B | 5.36B | 4.28B | 4.93B | 4.38B | 3.54B |
Balance Sheet | ||||||
| Total Assets | 67.14B | 74.64B | 69.96B | 66.14B | 60.14B | 55.82B |
| Cash, Cash Equivalents and Short-Term Investments | 18.84B | 20.75B | 21.34B | 16.93B | 14.51B | 14.32B |
| Total Debt | 2.78B | 2.74B | 2.87B | 3.07B | 2.67B | 2.42B |
| Total Liabilities | 15.13B | 17.09B | 16.40B | 16.07B | 14.88B | 15.61B |
| Stockholders Equity | 45.95B | 50.75B | 46.85B | 44.16B | 40.03B | 35.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.94B | 7.08B | 4.95B | 2.48B | 3.02B |
| Operating Cash Flow | 0.00 | 8.14B | 9.75B | 6.77B | 4.33B | 3.89B |
| Investing Cash Flow | 0.00 | -4.33B | -3.25B | -1.26B | -3.32B | -1.08B |
| Financing Cash Flow | 0.00 | -3.86B | -3.93B | -3.58B | -2.36B | -2.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥65.90B | 7.90 | ― | 3.95% | 2.75% | 25.75% | |
80 Outperform | ¥73.11B | 12.40 | ― | 2.63% | 2.11% | 0.91% | |
77 Outperform | ¥72.29B | 11.84 | ― | 2.79% | 4.22% | 7.91% | |
74 Outperform | ¥41.02B | 10.49 | ― | 3.95% | -4.76% | 20.37% | |
67 Neutral | ¥195.67B | 12.84 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥72.43B | 13.34 | ― | 3.09% | 7.43% | 47.68% |